Chronic calcineurin inhibitor nephrotoxicity: reflections on an evolving paradigm.
about
Factors influencing long-term outcome after kidney transplantationCalcineurin/NFAT signaling and innate host defence: a role for NOD1-mediated phagocytic functionsCalcineurin Undergoes a Conformational Switch Evoked via Peptidyl-Prolyl IsomerizationPathogenesis of calcineurin inhibitor-induced hypertensionTransition from cyclosporine-induced renal dysfunction to nephrotoxicity in an in vivo rat model.Epithelial-to-mesenchymal transition predicts cyclosporine nephrotoxicity in renal transplant recipients.Calcineurin (CN) activation promotes apoptosis of glomerular podocytes both in vitro and in vivoGq signaling causes glomerular injury by activating TRPC6.A randomized cross-over comparison of short-term exposure of once-daily extended release tacrolimus and twice-daily tacrolimus on renal function in healthy volunteers.Chronic progressive calcineurin nephrotoxicity: an overstated concept.Twenty years after ACEIs and ARBs: emerging treatment strategies for diabetic nephropathy.Challenges and considerations in diagnosing the kidney disease in deteriorating graft function.Insights into the possible mechanism of cyclosporine-induced chronic nephrotoxicity; arteriolopathyCalcineurin inhibitors: short-term friend, long-term foe?The accuracy of positron emission tomography in the detection of posttransplant lymphoproliferative disorder.Early Kidney Allograft Dysfunction (Threatened Allograft): Comparative Effectiveness of Continuing Versus Discontinuation of Tacrolimus and Use of Sirolimus to Prevent Graft Failure: A Retrospective Patient-Centered Outcome Study.Evaluation of the novel protein kinase C inhibitor sotrastaurin as immunosuppressive therapy after renal transplantation.Management of hematological malignancies in patients affected by renal failure.The impact of donor-specific anti-HLA antibodies on late kidney allograft failure.Proteinuria after kidney transplantation.An evaluation of sirolimus in renal transplantation.Pathophysiology and treatment options of chronic renal allograft damage.Complement as a multifaceted modulator of kidney transplant injury.Conversion from calcineurin inhibitor-based immunosuppression to mammalian target of rapamycin inhibitors or belatacept in renal transplant recipients.Treatment of severe lupus nephritis: the new horizon.The Evaluation and Therapeutic Management of Hypertension in the Transplant Patient.Belatacept-Resistant Rejection Is Associated With CD28+ Memory CD8 T Cells.Identification of expanded T-cell clones by spectratyping in nonfunctioning kidney transplants.New formulations of tacrolimus and prevention of acute and chronic rejections in adult kidney-transplant recipients.JAK3 inhibition: what potential for the future?Early post-transplant conversion from tacrolimus to belatacept for prolonged delayed graft function improves renal function in kidney transplant recipients.Experience with belatacept rescue therapy in kidney transplant recipients.Targets of new immunosuppressants in renal transplantation.Nox2 and Cyclosporine-Induced Renal Hypoxia.Impact of posttransplantation glomerulonephritis on long-term outcome of kidney transplants: single-center 20-year experience.Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients.Ten-year outcomes in a randomized phase II study of kidney transplant recipients administered belatacept 4-weekly or 8-weekly.Improving long-term renal allograft survival via a road less traveled by.Randomized phase 2b trial of tofacitinib (CP-690,550) in de novo kidney transplant patients: efficacy, renal function and safety at 1 year.Pathology of Calcineurin and Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation
P2860
Q26825480-62A365E0-FDEC-4937-ACBD-62677C9606B6Q26861114-9F4C12F9-F232-427C-A00B-34E25CE74E29Q28547077-58388AE9-A048-4ABB-84F5-7F5A9C0C9885Q33723923-132FE9B1-AEE8-4F33-81C1-3EE3A2858C51Q33755928-DF11E841-058D-4DFB-9C7A-B0EF4199EFF2Q35108909-D9A2384D-9CBD-4A02-80FC-AA0855C7F0D0Q35135695-9A62C23D-DF21-4285-ADCD-800D00A64E6FQ35719874-27E61854-BFDE-42DA-B41D-C92ED5A53BE9Q35835015-E7E056C0-DFC4-49C3-9A80-578E990443F2Q35929301-ACB1F417-C8D1-4809-B2F9-265DCEACE559Q36297539-5350C441-4F01-49DE-84AC-97FAD3F9E454Q36365811-5E360A77-B849-4EDC-839F-7730885C8913Q36734313-F9187AE3-4C35-44F6-982E-189BEED6CB51Q36769749-189E2C8A-1A87-4B87-B8E9-43BC2B07EACEQ36805870-49230B38-2974-4597-8863-68684DAE4346Q37346593-2B307418-454D-49CB-9A02-AA64A3AB61ADQ37818197-4DDD1E8B-2FF9-43A7-917A-ACF4E47020B7Q37854710-618B1369-F85E-4F7A-AF0C-63028B3188D9Q38003049-49D1070E-E604-41B9-8932-8051177DB090Q38012182-F8A9F668-31C5-40C5-B0CA-D9F94AA72870Q38038696-47628F86-B2EA-4D52-AC14-B9B6F10B85E3Q38102662-A9275842-9BF5-4C5E-B223-6026AC50A173Q38217273-47102771-20E1-45BB-BA76-18B80D046514Q38241710-2DC2BD5E-75D9-4632-8115-054D43D43479Q38271125-353830A1-A636-42B1-BCDC-74FDE26FF414Q38585232-5938B9DE-8B87-4552-ACC6-16D30842755EQ38787322-B888C3B6-D00F-4859-A297-6736896ED135Q38790777-0F591FEA-BE3D-436C-AAAE-2197D434EDFBQ38791651-9CDF46C4-C703-45B4-97B4-46A129F6746EQ39245527-110643A7-5781-466A-887A-9C2E876B81ABQ40335677-92566EEA-7FEB-4F51-A865-3C00290AD9BDQ40513558-4F7CDD4C-5488-45F2-8EAC-22CE88CF652DQ42727530-C37ECD0F-4BFE-4A58-B48F-A649C9AAEDA2Q42772736-533022E7-A381-4DF6-843D-B9397365E556Q43492328-915FCA6C-3F99-4CEA-9433-C6798169C5A7Q46007205-FCAB43F9-EE42-46A5-B499-988BAE364B7DQ46021679-DAFD2DD3-A793-46E7-A9C4-C1FA90DFC480Q53425445-902A16F8-822D-494D-A62B-BEE590E8E514Q54505605-FA95A48C-A395-4723-AA08-3D66088D9027Q57151742-927F3634-8255-4AA9-B01D-EE22896A42DE
P2860
Chronic calcineurin inhibitor nephrotoxicity: reflections on an evolving paradigm.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chronic calcineurin inhibitor nephrotoxicity: reflections on an evolving paradigm.
@en
Chronic calcineurin inhibitor nephrotoxicity: reflections on an evolving paradigm.
@nl
type
label
Chronic calcineurin inhibitor nephrotoxicity: reflections on an evolving paradigm.
@en
Chronic calcineurin inhibitor nephrotoxicity: reflections on an evolving paradigm.
@nl
prefLabel
Chronic calcineurin inhibitor nephrotoxicity: reflections on an evolving paradigm.
@en
Chronic calcineurin inhibitor nephrotoxicity: reflections on an evolving paradigm.
@nl
P356
P1476
Chronic calcineurin inhibitor nephrotoxicity: reflections on an evolving paradigm.
@en
P2093
Robert S Gaston
P304
P356
10.2215/CJN.03820609
P577
2009-10-22T00:00:00Z